Ifn-γ-independent intraocular tumor rejection is mediated by a macrophage-ependent process that leaves the eye intact

Journal of Leukocyte Biology

Volumn 92, Issue 5, 2012, Pages 939-950

  Coursey, Terry G ^a   Chen, Peter W ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anterior chamber; Immune privilege; M1 and M2; Phthisis

Indexed keywords

ARGININE; GAMMA INTERFERON; NO2 PROTEIN; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; EYE; INTRAOCULAR TUMOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR REJECTION;

ANIMALS; DISEASE MODELS, ANIMAL; EYE; EYE NEOPLASMS; FLOW CYTOMETRY; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION;

MURINAE;

EID: 84868323757     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0312122     Document Type: Article

References (52)

1. Whitsett, C. F., Stulting, R. D. (1984) The distribution of HLA antigens on human corneal tissue. Invest. Ophthalmol. Vis. Sci. 25, 519-524.
2. Streilein, J. W. (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879-889.
3. Niederkorn, J. Y. (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7, 354-359.
4. Niederkorn, J. Y. (2002) Immune privilege in the anterior chamber of the eye. Crit. Rev. Immunol. 22, 13-46.
5. Medawar, P. B. (1948) Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58-69.
6. Niederkorn, J. Y., Wang, S. (2005) Immunology of intraocular tumors. Ocul. Immunol. Inflamm. 13, 105-110.
7. Knisely, T. L., Luckenbach, M. W., Fischer, B. J., Niederkorn, J. Y (1987) Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 138, 4515-4523.
8. Knisely, T. L., Niederkorn, J. Y. (1990) Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Cancer Immunol. Immunother. 30, 323-330.
9. Schurmans, L. R., Diehl, L., den Boer, A. T., Sutmuller, R. P., Boon-man, Z. F., Medema, J. P., van der Voort, E. I., Laman, J., Melief, C. J., Jager, M. J., Toes, R E. (2001) Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis. J. Immunol. 167, 5832-5837.
10. Coursey, T. G., Chen, P. W., Niederkorn, J. Y (2011) Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors. Cancer Res. 71, 2445-2454
11. Adams, D. O. (1989) Molecular interactions in macrophage activation. Immunol. Today 10, 33-35.
12. Martinez, F. O., Sica, A, Mantovani, A, Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
13. Gruenheid, S., Gros, P. (2000) Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport. Curr. Opin. Microbiol. 3, 43-48.
14. Biswas, S. K, Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
15. Laskin, D. L., Sunil, V. R, Gardner, C. R, Laskin, J. D. (2011) Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 51, 267-288.
16. Owen, C. A. (2008) Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 3, 253-268.
17. Sica, A, Schioppa, T., Mantovani, A, Allavena, P. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727.
18. Coffelt, S. B., Hughes, R, Lewis, C. E. (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim. Bio-phys. Acta 1796, 11-18.
19. Van Ginderachter, J. A, Movahedi, K, Hassanzadeh Ghassabeh, G., Meerschaut, S., Beschin, A, Raes, G., De Baetselier, P. (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211, 487-501.
20. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y, Koseki, H., Kanno, M., Taniguchi, M. (1997) Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626.
21. Toes, R E., Offringa, R, Blom, R J., Brandt, R M., van der Eb, A. J., Melief, C. J., Kast, W. M. (1995) An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J. Immunol. 154, 3396-3405.
22. Schurmans, L. R, den Boer, A. T., Diehl, L., van der Voort, E. I., Kast, W. M., Melief, C. J., Toes, R E., Jager, M.J. (1999) Successful immunotherapy of an intraocular tumor in mice. Cancer Res. 59, 5250-5254.
23. Dace, D. S., Chen, P. W., Alizadeh, H., Niederkorn, J. Y (2007) Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-[γ]-dependent manner. J. Leukoc. Biol. 81, 421-429.
24. Cobbold, S. P., Jayasuriya, A., Nash, A, Prospero, T. D., Waldmann, H. (1984) Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548-551.
25. Coursey, T. G., Chen, P. W., Niederkorn, J. Y (2011) IL-17-dependent, IFN-[γ]-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. J. Immunol. 187, 4219-4228.
26. Ma, D., Alizadeh, H., Comerford, S. A, Gething, M. J., Sambrook, J. F., Anand, R, Niederkorn, J. Y (1994) Rejection of intraocular tumors from transgenic mice by tumor- infiltrating lymphocytes. Curr. Eye Res. 13, 361-369.
27. Cunnusamy, K, Chen, P. W., Niederkorn, J. Y (2010) IL-17 promotes immune privilege of corneal allografts. J. Immunol. 185, 4651-4658.
28. Cunnusamy, K, Chen, P. W., Niederkorn, J. Y (2011) IL-17A-dependent CD4 + CD25+ regulatory T cells promote immune privilege of corneal allografts. J. Immunol. 186, 6737-6745.
29. De Paiva, C. S., Chotikavanich, S., Pangelinan, S. B., Pitcher, J. D., 3rd, Fang, B., Zheng, X., Ma, P., Farley, W. J., Siemasko, K. F., Niederkorn, J. Y., Stern, M. E., Li, D. Q., Pflugfelder, S. C. (2009) IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2, 243-253.
30. Niederkorn, J., Streilein, J. W., Shadduck, J. A. (1981) Deviant immune responses to allogeneic tumors injected intracamerally and subcutane-ously in mice. Invest. Ophthalmol. Vis. Sci. 20, 355-363.
31. Van Rooijen, N. (1989) The liposome-mediated macrophage "suicide" technique. J. Immunol. Methods 124, 1-6.
32. Van Klink, F., Taylor, W. M., Alizadeh, H., Jager, M. J., van Rooijen, N., Niederkorn, J. Y (1996) The role of macrophages in Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 37, 1271-1281.
33. Boonman, Z. F., Schurmans, L. R, van Rooijen, N., Melief, C. J., Toes, R E., Jager, M.J. (2006) Macrophages are vital in spontaneous intraocular tumor eradication. Invest. Ophthalmol. Vis. Sci. 47, 2959-2965.
34. Dace, D. S., Chen, P. W., Niederkorn, J. Y (2008) CD4+ T-cell-depen-dent tumour rejection in an immune-privileged environment requires macrophages. Immunology 123, 367-377.
35. Zhang X. G. R, Mosser, D. M. (2008) The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14.1.
36. Shinohara, H., Yano, S., Bucana, C. D., Fidler, I.J. (2000) Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells. J. Immunol. 164, 2728-2737.
37. Nascimento, F. R, Ribeiro-Dias, F., Russo, M. (1998) Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz. J. Med. Biol. Res. 31, 1593-1596.
38. Yamaguchi, H., Kidachi, Y, Umetsu, H., Ryoyama, K. (2008) L-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-α from macrophages. Mol. Cell. Biochem. 312, 103-112.
39. Allavena, P., Sica, A, Garlanda, C, Mantovani, A. (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222, 155-161.
40. Dace, D. S., Chen, P. W., Niederkorn, J. Y (2007) CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-α-dependent mechanism. J. Immunol. 178, 6115-6122.
41. Niederkorn, J. Y, Knisely, T. L. (1988) Immunological analysis of a destructive pattern of intraocular tumor resolution. Curr. Eye Res. 7, 515-526.
42. Mantovani, A, Schioppa, T., Porta, C, Allavena, P., Sica, A. (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 25, 315-322.
43. Peponis, V., Papathanasiou, M., Kapranou, A, Magkou, C, Tyligada, A, Melidonis, A, Drosos, T., Sitaras, N. M. (2002) Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br. J. Ophthalmol. 86, 1369-1373.
44. Bourboulia, D., Stetler-Stevenson, W. G. (2010) Matrix metalloprotei-nases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin. Cancer Biol. 20, 161-168.
45. Yi, C. H., Yuan, J. (2009) The Jekyll and Hyde functions of caspases. Dev. Cell 16, 21-34.
46. Minarowska, A, Minarowski, L., Karwowska, A, Gacko, M. (2007) Regulatory role of cathepsin D in apoptosis. Folia Histochem. Cytobiol. 45, 159-163.
47. Kim, W. J., Kim, H., Suk, K., Lee, W. H. (2007) Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis. Immunol. Lett. 111, 57-65.
48. Harris, J. L., Peterson, E. P., Hudig, D., Thornberry, N. A, Craik, C. S. (1998) Definition and redesign of the extended substrate specificity of granzyme B. J. Biol. Chem. 273, 27364-27373.
49. Thornberry, N. A, Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V M., Nordstrom, P. A, Roy, S., Vail-lancourt, J. P., Chapman, K. T., Nicholson, D. W. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911.
50. Scaffidi, P., Misteli, T., Bianchi, M. E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191- 195.
51. Lederle, W., Hartenstein, B., Meides, A, Kunzelmann, H., Werb, Z., Angel, P., Mueller, M. M. (2010) MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 31, 1175-1184.
52. Liu, Y, Mei, J., Gonzales, L., Yang, G., Dai, N., Wang, P., Zhang, P., Fa-vara, M., Malcolm, K. C, Guttentag, S., Worthen, G. S. (2011) IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J. Immunol. 186, 3197-3205.